Rigel Pharmaceuticals (RIGL) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 1.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27% |
| Dec 31, 2025 | 49.22% |
| Sep 30, 2025 | 122.37% |
| Jun 30, 2025 | 5,923.50% |
| Mar 31, 2025 | 239.58% |
| Dec 31, 2024 | 1,965.40% |
| Sep 30, 2024 | 318.22% |
| Jun 30, 2024 | 84.39% |
| Mar 31, 2024 | 39.07% |
| Dec 31, 2023 | -47.39% |
| Sep 30, 2023 | 70.10% |
| Jun 30, 2023 | 51.08% |
| Mar 31, 2023 | 50.68% |
| Dec 31, 2022 | 106.17% |
| Sep 30, 2022 | 9.73% |
| Jun 30, 2022 | 8.78% |
| Mar 31, 2022 | -166.50% |
| Dec 31, 2021 | -18.01% |
| Sep 30, 2021 | -48.78% |
| Jun 30, 2021 | 15.85% |
| Mar 31, 2021 | 94.28% |
| Dec 31, 2020 | -11.84% |
| Sep 30, 2020 | -23.36% |
| Jun 30, 2020 | 14.70% |
| Mar 31, 2020 | 220.71% |
| Dec 31, 2019 | -632.84% |
| Sep 30, 2019 | 51.65% |
| Jun 30, 2019 | 19.37% |
| Mar 31, 2019 | 27.83% |
| Dec 31, 2018 | 112.48% |
| Sep 30, 2018 | -34.58% |
| Jun 30, 2018 | -33.48% |
| Mar 31, 2018 | -51.97% |
| Dec 31, 2017 | -65.01% |
| Sep 30, 2017 | 21.96% |
| Jun 30, 2017 | -41.48% |
| Mar 31, 2017 | 8.12% |
| Dec 31, 2016 | -23.58% |
| Sep 30, 2016 | -236.39% |
| Jun 30, 2016 | 2.72% |
| Mar 31, 2016 | 4.01% |
| Dec 31, 2015 | 43.17% |
| Sep 30, 2015 | 67.95% |
| Jun 30, 2015 | 45.21% |
| Mar 31, 2015 | 18.43% |
| Dec 31, 2014 | -32.27% |
| Sep 30, 2014 | 11.91% |
| Jun 30, 2014 | -11.52% |
| Mar 31, 2014 | 12.79% |
| Dec 31, 2013 | 33.79% |
| Sep 30, 2013 | 6.41% |
| Jun 30, 2013 | 7.96% |
| Mar 31, 2013 | -10.36% |
| Dec 31, 2012 | 1.16% |
| Sep 30, 2012 | -41.97% |
| Jun 30, 2012 | -15.20% |
| Mar 31, 2012 | -11.52% |
| Dec 31, 2011 | -31.57% |
| Sep 30, 2011 | -135.55% |
| Jun 30, 2011 | -179.45% |